Sei Investments Co. Acquires 628 Shares of Huron Consulting Group Inc. (NASDAQ:HURN)

Sei Investments Co. lifted its holdings in shares of Huron Consulting Group Inc. (NASDAQ:HURN) by 0.4% in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 152,931 shares of the business services provider’s stock after acquiring an additional 628 shares during the quarter. Sei Investments Co.’s holdings in Huron Consulting Group were worth $15,064,000 as of its most recent SEC filing.

Other institutional investors have also made changes to their positions in the company. ProShare Advisors LLC lifted its holdings in Huron Consulting Group by 6.0% during the 1st quarter. ProShare Advisors LLC now owns 3,342 shares of the business services provider’s stock valued at $323,000 after purchasing an additional 188 shares during the last quarter. Blair William & Co. IL boosted its holdings in shares of Huron Consulting Group by 2.1% during the 1st quarter. Blair William & Co. IL now owns 10,512 shares of the business services provider’s stock worth $1,016,000 after buying an additional 218 shares during the period. Covestor Ltd boosted its holdings in shares of Huron Consulting Group by 26,500.0% during the 1st quarter. Covestor Ltd now owns 266 shares of the business services provider’s stock worth $26,000 after buying an additional 265 shares during the period. Ashton Thomas Private Wealth LLC bought a new position in Huron Consulting Group in the 2nd quarter valued at about $28,000. Finally, Diversified Trust Co lifted its position in Huron Consulting Group by 7.5% during the second quarter. Diversified Trust Co now owns 5,452 shares of the business services provider’s stock worth $537,000 after acquiring an additional 380 shares during the last quarter. 93.90% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling at Huron Consulting Group

In other news, Director H Eugene Lockhart sold 1,042 shares of the stock in a transaction on Tuesday, September 3rd. The stock was sold at an average price of $109.48, for a total value of $114,078.16. Following the completion of the transaction, the director now directly owns 29,882 shares in the company, valued at approximately $3,271,481.36. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. In other Huron Consulting Group news, Director H Eugene Lockhart sold 1,042 shares of the company’s stock in a transaction that occurred on Tuesday, September 3rd. The shares were sold at an average price of $109.48, for a total value of $114,078.16. Following the completion of the transaction, the director now directly owns 29,882 shares in the company, valued at approximately $3,271,481.36. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Also, CEO C. Mark Hussey sold 4,000 shares of the business’s stock in a transaction on Monday, August 12th. The stock was sold at an average price of $103.13, for a total transaction of $412,520.00. Following the completion of the sale, the chief executive officer now directly owns 81,081 shares in the company, valued at approximately $8,361,883.53. The disclosure for this sale can be found here. Insiders have sold a total of 44,439 shares of company stock worth $4,512,214 over the last 90 days. Insiders own 2.02% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities analysts have recently commented on HURN shares. Barrington Research reaffirmed an “outperform” rating and issued a $137.00 target price on shares of Huron Consulting Group in a research report on Monday, September 9th. Benchmark reiterated a “buy” rating and set a $140.00 price objective on shares of Huron Consulting Group in a research report on Wednesday, July 31st. Finally, StockNews.com raised shares of Huron Consulting Group from a “sell” rating to a “hold” rating in a research report on Saturday, August 3rd. One analyst has rated the stock with a hold rating and four have issued a buy rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $131.75.

Huron Consulting Group Price Performance

Huron Consulting Group stock opened at $108.10 on Friday. The firm has a market cap of $1.95 billion, a PE ratio of 31.15 and a beta of 0.61. The company has a debt-to-equity ratio of 0.99, a current ratio of 1.93 and a quick ratio of 1.93. The stock’s fifty day moving average price is $107.34 and its two-hundred day moving average price is $98.63. Huron Consulting Group Inc. has a one year low of $84.26 and a one year high of $115.65.

Huron Consulting Group (NASDAQ:HURN) last issued its quarterly earnings results on Tuesday, July 30th. The business services provider reported $1.68 EPS for the quarter, topping analysts’ consensus estimates of $1.48 by $0.20. Huron Consulting Group had a return on equity of 20.44% and a net margin of 5.46%. The company had revenue of $371.70 million for the quarter, compared to analysts’ expectations of $374.33 million. During the same quarter last year, the business earned $1.38 earnings per share. Huron Consulting Group’s revenue was up 7.2% on a year-over-year basis. As a group, research analysts expect that Huron Consulting Group Inc. will post 5.95 EPS for the current fiscal year.

Huron Consulting Group Company Profile

Huron Consulting Group Inc, a professional services firm, provides consultancy services in the United States and internationally. It operates through three segments: Healthcare, Education, and Commercial. The Healthcare segment provides financial and operational performance improvement consulting services; digital offerings, spanning technology and analytic-related services; software products; organizational transformation services; revenue cycle managed and outsourcing services; financial and capital advisory consulting services; and strategy and innovation consulting services to national and regional health systems, academic and community health systems, federal health system, public, children’s and critical access hospitals, physician practices and medical groups, payors, and long-term care or post-acute providers.